Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Stephen Okland Insider Profile
4 Followers
Stephen Okland, VP Sales at Spectranetics, holds 0.00 shares in Spectranetics (Ticker: SPNC), holds 23.64K shares in Second Sight Medical Products (Ticker: EYES). Most recently, Stephen Okland ― shares of Spectranetics on ― for an estimated value of ―.
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+39.60%
Average return per transaction
Time Frame
Compare to
Insider Roles
CCO
Roles that Stephen Okland holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jun 01, 2018 - Jun 01, 2019
Return:+61.60%
The most profitable trade made by Stephen Okland
Stephen Okland's Trading History
Spectranetics
―
―
―
$0.00
Second Sight Medical Products
Dec 04, 2018
CCO
Uninformative Buy
$7.07K
$25.77K
List of latest transactions for each holding click on a transaction to see Stephen Okland's performance on stock
You May Also Like
Stephen Okland insider profile FAQ
What is the percentage of profitable transactions made by Stephen Okland?
The percentage of profitable transactions made by Stephen Okland is 100%.
What is the average return per transaction made by Stephen Okland?
The average return per transaction made by Stephen Okland is 39.60%.
What stocks does Stephen Okland hold?
Stephen Okland holds: SPNC, EYES stocks.
What was Stephen Okland’s latest transaction?
Stephen Okland latest transaction was an Uninformative Buy of ―.
What was Stephen Okland's most profitable transaction?
Stephen Okland’s most profitable transaction was an Informative Sell of EYES stock on June 1, 2018. The return on the trade was 61.60%.
What is Stephen Okland's role in Spectranetics?
Stephen Okland's role in Spectranetics is VP Sales.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.